<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Support Care Cancer</journal-id><journal-id journal-id-type="iso-abbrev">Support Care Cancer</journal-id><journal-title-group><journal-title>Supportive Care in Cancer</journal-title></journal-title-group><issn pub-type="ppub">0941-4355</issn><issn pub-type="epub">1433-7339</issn><publisher><publisher-name>Springer Berlin Heidelberg</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28365896</article-id><article-id pub-id-type="pmc">5527056</article-id><article-id pub-id-type="publisher-id">3676</article-id><article-id pub-id-type="doi">10.1007/s00520-017-3676-x</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Voice rehabilitation after laryngeal cancer: Associated effects on psychological well-being</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6749-9390</contrib-id><name><surname>Bergstr&#x000f6;m</surname><given-names>Liza</given-names></name><address><phone>+61 38963081</phone><email>liza.bergstrom@uq.net.au</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Ward</surname><given-names>Elizabeth C</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Finizia</surname><given-names>Caterina</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9919 9582</institution-id><institution-id institution-id-type="GRID">grid.8761.8</institution-id><institution>Department of Otorhinolaryngology, </institution><institution>The Sahlgrenska Academy at the University of Gothenburg, </institution></institution-wrap>Gothenberg, Sweden </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9320 7537</institution-id><institution-id institution-id-type="GRID">grid.1003.2</institution-id><institution>School of Health and Rehabilitation Sciences, </institution><institution>University of Queensland, </institution></institution-wrap>Brisbane, Australia </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0380 0804</institution-id><institution-id institution-id-type="GRID">grid.415606.0</institution-id><institution>Center for Functioning and Health Research (CFAHR), </institution><institution>Queensland Health, </institution></institution-wrap>Brisbane, Australia </aff></contrib-group><pub-date pub-type="epub"><day>2</day><month>4</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>2</day><month>4</month><year>2017</year></pub-date><pub-date pub-type="ppub"><year>2017</year></pub-date><volume>25</volume><issue>9</issue><fpage>2683</fpage><lpage>2690</lpage><history><date date-type="received"><day>26</day><month>9</month><year>2016</year></date><date date-type="accepted"><day>15</day><month>3</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2017</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p></license></permissions><abstract id="Abs1"><sec><title>Purpose</title><p id="Par1">Psychological distress after laryngeal cancer treatment is prevalent. Although voice rehabilitation has shown to improve functional outcomes and positively affect health-related quality of life, to date, there has been limited study of the associated effect of behavioural voice intervention on psychological well-being/distress post laryngeal cancer.</p></sec><sec><title>Method</title><p id="Par2">Sixty-three patients with Tis-T4 laryngeal cancer treated with (chemo)radiotherapy were prospectively recruited and randomised to either a voice rehabilitation (VR, <italic>n</italic>&#x000a0;=&#x000a0;31) or control group (<italic>n</italic>&#x000a0;=&#x000a0;32). The VR group received 10 speech pathology sessions consisting of both direct and indirect voice intervention post (chemo)radiotherapy. The control group received general voice education but not specific intervention. As part of a multidisciplinary assessment battery, psychological well-being/distress was measured using the Hospital Anxiety and Depression Scale (HADS) pre, six and 12&#x000a0;months post VR.</p></sec><sec><title>Results</title><p id="Par3">Within-group analysis revealed a significant (<italic>p</italic>&#x000a0;=&#x000a0;0.03) reduction in the proportion of patients with anxiety in the VR group between baseline and 12&#x000a0;months. No change over time was observed in controls. Between-group analysis revealed a trend for fewer VR cases demonstrating anxiety (<italic>p</italic>&#x000a0;=&#x000a0;0.06) or depression (<italic>p</italic>&#x000a0;=&#x000a0;0.08) at 6&#x000a0;months and significantly fewer demonstrating anxiety (<italic>p</italic>&#x000a0;=&#x000a0;0.04) and depression (<italic>p</italic>&#x000a0;=&#x000a0;0.04) at 12&#x000a0;months, compared to controls. Significant correlations were observed between patients&#x02019; voice perceptions and reduced anxiety (<italic>r</italic>
<sub>pb</sub>&#x000a0;=&#x000a0;&#x02212;0.38) and depression (<italic>r</italic>
<sub>pb</sub>&#x000a0;=&#x000a0;&#x02212;0.66) within the VR group at 12&#x000a0;months.</p></sec><sec><title>Conclusions</title><p id="Par4">The positive correlations and between-group analyses indicate a positive effect on psychological well-being associated with completing voice rehabilitation. Results highlight potential additional benefits of behavioural voice intervention beyond achieving direct change to voice function.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Voice therapy</kwd><kwd>Speech-language pathology</kwd><kwd>Radiotherapy</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000944</institution-id><institution>Speech Pathology Australia</institution></institution-wrap></funding-source></award-group><award-group><funding-source><institution>Queensland Registration Board Legacy Fund</institution></funding-source></award-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100005009</institution-id><institution>Stiftelsen Assar Gabrielssons Fond</institution></institution-wrap></funding-source></award-group><award-group><funding-source><institution>Lions Cancer Foundation West, Sweden</institution></funding-source></award-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002794</institution-id><institution>Cancerfonden</institution></institution-wrap></funding-source></award-group><award-group><funding-source><institution>Larynxfonden</institution></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer-Verlag GmbH Germany 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par5">Within head and neck cancer (HNC) research and clinical management, greater importance is now being placed on understanding the sequelae impacting patients post cancer treatment. Such information is essential to guide rehabilitation and optimise patient function, psychological health and quality of life for improved survivorship care following cancer. Within the subgroup of patients who present with laryngeal cancer managed with organ-preservation treatments, the negative impacts of (chemo)radiotherapy [(C)RT] treatment on function, health-related quality of life (HRQL) and psychological well-being/distress have been investigated to varied extents.</p><p id="Par6">Regarding impact to voice function and communication after laryngeal cancer treatment, research indicates that patients will experience vocal function changes that vary from mild to severe in nature. Often presenting as a complex dysphonia, the voice post (C)RT has been characterised as harsh, rough, strained and breathy, with glottal fry and altered pitch which may remain with the patient long term [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR5">5</xref>]. Patients themselves report poor vocal quality, hoarseness, reduced volume and vocal fatigue following laryngeal cancer treatment [<xref ref-type="bibr" rid="CR6">6</xref>&#x02013;<xref ref-type="bibr" rid="CR9">9</xref>].</p><p id="Par7">Many studies have also investigated (HRQL) and global quality of life (QOL) outcomes post laryngeal cancer. Research specific to non-surgical treatment outcomes indicates that the majority of HRQL (function and symptom scales) deteriorate 1&#x000a0;month post radiotherapy then improve 6&#x02013;12&#x000a0;months to reach baseline levels (pre-radiotherapy), although these remain below normative values [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. Most HRQL function and symptom outcomes present at 12&#x000a0;months continue to persist long term, up to 5&#x000a0;years post radiotherapy [<xref ref-type="bibr" rid="CR11">11</xref>].</p><p id="Par8">However, whilst the impact on functional outcomes and quality of life has been well explored, research into patient <italic>psychological well-being</italic>/<italic>distress</italic> post laryngeal cancer has been examined to a lesser extent. Studies suggest that up to 41% of patients experience possible/probable anxiety or depression [<xref ref-type="bibr" rid="CR12">12</xref>] which may be most prevalent either pre-radiotherapy [<xref ref-type="bibr" rid="CR10">10</xref>] or 12&#x000a0;months post [<xref ref-type="bibr" rid="CR13">13</xref>] and continues to persist years after management [<xref ref-type="bibr" rid="CR14">14</xref>]. Johansson and colleagues (2011) also identified that patients&#x02019; mental adjustment to laryngeal cancer and their coping strategies significantly impact anxiety, depression, HRQL and survival [<xref ref-type="bibr" rid="CR15">15</xref>].</p><p id="Par9">Given the extent of functional impairments and reduced quality of life outcomes after laryngeal cancer treatment, recent research has explored potential benefits of behavioural voice rehabilitation for this clinical group. Studies indicate that voice rehabilitation post laryngeal cancer significantly improves voice (acoustic and perceptual qualities), patient perceptions, communication and several HRQL outcomes when compared to a laryngeal cancer cohort who did not receive voice rehabilitation [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR16">16</xref>&#x02013;<xref ref-type="bibr" rid="CR19">19</xref>]. Furthermore, there is a known interrelationship between function, quality of life and patient well-being. Rinkel and colleagues (2014) highlighted that, specifically within the laryngeal cancer population, the prevalence of voice, communication (and swallowing) problems after laryngeal cancer treatment is high and clearly related to quality of life and emotional distress [<xref ref-type="bibr" rid="CR20">20</xref>]. Consequently, it could be hypothesised that patients who receive rehabilitation for their voice deficits following laryngeal cancer, and experience positive functional and HRQL effects, may also experience positive benefits for their psychological well-being.</p><p id="Par10">However, whilst results from rehabilitation trials have demonstrated improved voice function and positive impacts to HRQL outcomes, to date, any potential impact on psychological well-being has not been examined. Given the interrelationship between function, HRQL and psychological well-being, this study aims to determine if there is also an associated effect on patient well-being/distress, specifically experiences of anxiety and/or depression for patients who receive behavioural voice intervention following (chemo)radiotherapy for laryngeal cancer.</p></sec><sec id="Sec2"><title>Methodology</title><sec id="Sec3"><title>Study population</title><p id="Par11">The current data were collected as part of a larger, prospective randomised control trial at Sahlgrenska University Hospital, Gothenburg, Sweden [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. Ethical approval was granted and the study was conducted in accordance with the Declaration of Helsinki. Patients diagnosed with laryngeal cancer (Tis-T4) in the V&#x000e4;stra G&#x000f6;taland Region were referred to a weekly tumour conference at the Otorhinolaryngology Department and invited to be part of the study. Inclusion criteria for the study were laryngeal cancer patients planned for curative (chemo)radiotherapy, who had sufficient Swedish language competency to independently answer questionnaires and partake in voice rehabilitation. Exclusion criteria were tracheostomy and severe cognitive impairment limiting participation in voice rehabilitative exercises. A total of 163 patients were available for inclusion, of which 89 agreed to participate or remained eligible for study participation (CONSORT flow diagram, Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Randomisation occurred electronically using Pocock&#x02019;s sequential randomisation method [<xref ref-type="bibr" rid="CR21">21</xref>] considering patient&#x02019;s age, smoking status, tumour site, size and self-evaluation of communication pre (C)RT. Twenty-six patients were lost to follow-up, leaving a total of 63 patients available for analyses. Comparisons of the demographics between the two groups confirmed there were no significant differences between the voice rehabilitation (VR) and control groups when compared for gender, mean age, tumour location, radiotherapy regime, comorbidity or working status (Table <xref rid="Tab1" ref-type="table">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>Consolidated Standards of Reporting Trials (CONSORT) flow diagram</p></caption><graphic xlink:href="520_2017_3676_Fig1_HTML" id="MO1"/></fig>
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Patient inclusion demographics</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>Control group <italic>n</italic> (%)</th><th>Voice rehabilitation <italic>n</italic> (%)</th><th>Difference <italic>p</italic> value</th></tr></thead><tbody><tr><td>Patients</td><td>32</td><td>31</td><td/></tr><tr><td>&#x02003;Gender</td><td/><td/><td char="." align="char">0.96</td></tr><tr><td>&#x02003;&#x02003;Male</td><td>28 (87)</td><td>27 (87)</td><td/></tr><tr><td>&#x02003;&#x02003;Female</td><td>4 (13)</td><td>4 (13)</td><td/></tr><tr><td>&#x02003;Mean age (years)</td><td>62.1</td><td>65.8</td><td char="." align="char">0.19</td></tr><tr><td>&#x02003;Range</td><td>41&#x02013;82</td><td>41&#x02013;86</td><td char="." align="char"/></tr><tr><td>Tumour location</td><td/><td/><td char="." align="char">0.59</td></tr><tr><td>&#x02003;Glottic (78%)</td><td>24 (75)</td><td>25 (81)</td><td/></tr><tr><td>&#x02003;&#x02003;Tis</td><td>1</td><td>0</td><td/></tr><tr><td>&#x02003;&#x02003;T1</td><td>15</td><td>19</td><td/></tr><tr><td>&#x02003;&#x02003;T2</td><td>7</td><td>6</td><td/></tr><tr><td>&#x02003;&#x02003;T3</td><td>1</td><td>0</td><td/></tr><tr><td>&#x02003;Supraglottic (22%)</td><td>8 (25)</td><td>6 (19)</td><td/></tr><tr><td>&#x02003;&#x02003;T1</td><td>1</td><td>2</td><td/></tr><tr><td>&#x02003;&#x02003;T2</td><td>3</td><td>2</td><td/></tr><tr><td>&#x02003;&#x02003;T3</td><td>4</td><td>1</td><td/></tr><tr><td>&#x02003;&#x02003;T4</td><td>0</td><td>1</td><td/></tr><tr><td>Radiotherapy</td><td/><td/><td char="." align="char">0.46</td></tr><tr><td>&#x02003;Conventional</td><td>23 (72)</td><td>19 (61)</td><td/></tr><tr><td>&#x02003;Hyperfractionated</td><td>9 (28)</td><td>12 (39)</td><td/></tr><tr><td>Comorbidity (ACE-27)<sup>a</sup>
</td><td>(<italic>n</italic>&#x000a0;=&#x000a0;31)<sup>b</sup>
</td><td/><td char="." align="char">0.22</td></tr><tr><td>&#x02003;None</td><td>13&#x000a0;=&#x000a0;(42)</td><td>13&#x000a0;=&#x000a0;(42)</td><td/></tr><tr><td>&#x02003;Mild</td><td>14&#x000a0;=&#x000a0;(45)</td><td>9&#x000a0;=&#x000a0;(29)</td><td/></tr><tr><td>&#x02003;Moderate</td><td>4&#x000a0;=&#x000a0;(13)</td><td>9&#x000a0;=&#x000a0;(29)</td><td/></tr><tr><td>&#x02003;Severe</td><td>0</td><td>0</td><td/></tr><tr><td>Working status&#x02014;employed</td><td>14 (44)</td><td>12 (39)</td><td char="." align="char">0.69</td></tr><tr><td>Vocally demanding work<sup>c</sup>
</td><td>7/14 (50)</td><td>7/12 (58)</td><td char="." align="char">0.95</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>Adult Comorbidity Evaluation (ACE-27) [<xref ref-type="bibr" rid="CR35">35</xref>]</p><p>
<sup>b</sup>One patient with missing data</p><p>
<sup>c</sup>As determined by patient report</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec4"><title>Oncologic treatment</title><p id="Par12">The radiotherapy regime, as determined by regional guidelines, was either (1) conventional, once daily radiotherapy at 2&#x02013;2.4&#x000a0;Gy fractions to a total of 62.4&#x02013;68&#x000a0;Gy, or (2) hyperfractionated, twice daily radiotherapy at 1.7&#x000a0;Gy fractions to a total of 64.6&#x000a0;Gy. Patients with T2&#x02013;T4 tumours generally received radiation to lymph nodes (<italic>n</italic>&#x000a0;=&#x000a0;24) and three patients with T3&#x02013;T4 tumours also received induction chemotherapy.</p></sec><sec id="Sec5"><title>Procedure</title><p id="Par13">Outcome assessments occurred at baseline, i.e., 1&#x000a0;month post (chemo)radiotherapy cessation (pre-voice rehabilitation), and post voice rehabilitation at 6 and at 12&#x000a0;months post (C)RT. At each time point, all patients completed an assessment battery including voice recording and analyses, self-reported communication experiences and health-related quality of life measures. These results have been previously reported [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. For the current study, only the data relating to patient perceptions of their voice acceptability and the data relating to patient well-being, as reported by the Hospital Anxiety and Depression Scale [<xref ref-type="bibr" rid="CR22">22</xref>], is examined. The Hospital Anxiety and Depression Scale (HADS) was developed for the general medical patient population and has been used extensively both clinically and within research [<xref ref-type="bibr" rid="CR23">23</xref>]. It consists of the two scales, anxiety and depression, each with seven questions answered on a 0&#x02013;3 scale, where a larger number represents greater symptoms of anxiety/depression. Within each scale, summated scores of &#x0003c;8 indicate no case of anxiety/depression, scores of 8&#x02013;10 indicate possible anxiety/depression and scores &#x02265;11 indicate probable anxiety/depression [<xref ref-type="bibr" rid="CR22">22</xref>]. Patient&#x02019;s voice perceptions were examined using a study-specific questionnaire, reported in earlier studies [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. However, from this, only the question examining whether the patient believed their voice to be acceptable in a social environment, answered on a Likert scale with 0 = never, 1 = sometimes, 2 = often and 3 = always, was included in this study.</p><p id="Par14">Voice rehabilitation occurred between pre-voice rehabilitation (1&#x000a0;month post treatment) and the 6-month post (C)RT time point. Voice rehabilitation consisted of 10 speech pathology intervention sessions over 10&#x000a0;weeks using a structured protocol consisting of both direct and indirect voice intervention, including tasks such as breathing, relaxing, posture and specific physiology-targeted phonation exercises [<xref ref-type="bibr" rid="CR9">9</xref>]. The final sessions focused on transferability of skills and generalisation into conversation and holistic communication. The control group received general voice education such as vocal hygiene advice, but not specific intervention.</p></sec><sec id="Sec6"><title>Statistical methods</title><p id="Par15">Descriptive statistics were used to calculate the proportion of HADS &#x02018;no case&#x02019; versus &#x02018;possible/probable&#x02019; anxiety and depression. Within- and between-group statistical analyses were conducted using SPSS statistics software, version 22, with a significance set at <italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05. Within-group analysis (across time points) was calculated using the McNemar chi-square test for categorical data. Difference between groups was calculated using the chi-square statistic. Correlation between possible/probable anxiety or depression (dichotomous variable) and patient voice perceptions (ordinal data) was calculated using point-biserial correlation coefficient (<italic>r</italic>
<sub>pb</sub>) using VassarStats: Website for Statistical Computation [<xref ref-type="bibr" rid="CR26">26</xref>]. Correlation strength was interpreted using the following criteria: 0.00&#x02013;0.30 = negligible correlation, 0.30&#x02013;0.50 = low correlation, 0.50&#x02013;0.70 = moderate correlation, 0.70&#x02013;0.90 = high correlation and 0.90&#x02013;1.00 = very high correlation [<xref ref-type="bibr" rid="CR27">27</xref>].</p></sec></sec><sec id="Sec7"><title>Results</title><p id="Par16">Within- and between-group comparisons are displayed in Table <xref rid="Tab2" ref-type="table">2</xref>. Within-group analysis showed a trend (<italic>p</italic>&#x000a0;=&#x000a0;0.06), in the VR group, towards a reduction in number of possible/probable <italic>anxiety</italic> cases at 6&#x000a0;months, and by 12&#x000a0;months, the number of possible/probable <italic>anxiety</italic> cases was significantly lower (<italic>p</italic>&#x000a0;=&#x000a0;0.03) than pre-voice rehabilitation. No significant change in cases of <italic>depression</italic>, in the VR group, was observed over time. For the control group, no changes were observed in the proportion of patients reporting anxiety or depression across any of the time points.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Between- and within-group analysis of the proportion of patients with no, possible or probable anxiety and depression at each time point</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"/><th rowspan="2">Pre-VR number (%)</th><th rowspan="2">6&#x000a0;months number (%)</th><th rowspan="2">12&#x000a0;months number (%)</th><th colspan="3">Within-group analysis</th></tr><tr><th>Pre-VR to 6 months <italic>p</italic> value</th><th>6 to 12&#x000a0;months <italic>p</italic> value</th><th>Pre-VR to 12&#x000a0;months <italic>p</italic> value</th></tr></thead><tbody><tr><td colspan="7">Control group</td></tr><tr><td>&#x02003;Anxiety</td><td/><td/><td/><td/><td/><td/></tr><tr><td>&#x02003;&#x02003;No case</td><td>21 (66)</td><td>23 (72)</td><td>24 (75)</td><td char="." align="char" rowspan="2">0.73</td><td char="." align="char" rowspan="2">1.00</td><td char="." align="char" rowspan="2">0.38</td></tr><tr><td>&#x02003;&#x02003;Possible/probable</td><td>11 (34)</td><td>9 (28)</td><td>8 (25)</td></tr><tr><td>&#x02003;Depression</td><td/><td/><td/><td/><td/><td/></tr><tr><td>&#x02003;&#x02003;No case</td><td>20 (63)</td><td>25 (78)</td><td>24 (75)</td><td char="." align="char" rowspan="2">0.18</td><td char="." align="char" rowspan="2">1.00</td><td char="." align="char" rowspan="2">0.22</td></tr><tr><td>&#x02003;&#x02003;Possible/probable</td><td>12 (37)</td><td>7 (22)</td><td>8 (25)</td></tr><tr><td colspan="7">VR group</td></tr><tr><td>&#x02003;Anxiety</td><td/><td/><td/><td/><td/><td/></tr><tr><td>&#x02003;&#x02003;No case</td><td>23 (74)</td><td>28 (90)</td><td>29 (94)</td><td char="." align="char" rowspan="2">0.06</td><td char="." align="char" rowspan="2">1.00</td><td char="." align="char" rowspan="2">
<italic>0.03</italic>
</td></tr><tr><td>&#x02003;&#x02003;Possible/probable</td><td>8 (26)</td><td>3 (10)</td><td>2 (6)</td></tr><tr><td>&#x02003;Depression</td><td/><td/><td/><td/><td/><td/></tr><tr><td>&#x02003;&#x02003;No case</td><td>25 (81)</td><td>29 (94)</td><td>29 (94)</td><td char="." align="char" rowspan="2">0.29</td><td char="." align="char" rowspan="2">1.00</td><td char="." align="char" rowspan="2">0.22</td></tr><tr><td>&#x02003;&#x02003;Possible/probable</td><td>6 (19)</td><td>2 (6)</td><td>2 (6)</td></tr><tr><td colspan="7">Between-group analysis</td></tr><tr><td>&#x02003;Anxiety</td><td>
<italic>p&#x000a0;=</italic>&#x000a0;0.50</td><td>
<italic>p&#x000a0;=</italic>&#x000a0;0.06</td><td>
<italic>p&#x000a0;=&#x000a0;0.04</italic>
</td><td/><td/><td/></tr><tr><td>&#x02003;Depression</td><td>
<italic>p&#x000a0;=</italic>&#x000a0;0.11</td><td>
<italic>p&#x000a0;=</italic>&#x000a0;0.08</td><td>
<italic>p&#x000a0;=&#x000a0;0.04</italic>
</td><td/><td/><td/></tr></tbody></table><table-wrap-foot><p>Statistical significance (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05) indicated by italic font</p><p>
<italic>VR</italic> voice rehabilitation</p></table-wrap-foot></table-wrap>
</p><p id="Par17">Between-group analyses revealed no significant difference between groups at baseline; however, at 6&#x000a0;months, the VR group reported less cases of possible/probable anxiety and depression, a difference approaching significance (<italic>p&#x000a0;=</italic>&#x000a0;0.06 and <italic>p</italic>&#x000a0;=&#x000a0;0.08, respectively). By 12&#x000a0;months, however, the two groups were statistically significantly different (<italic>p</italic>&#x000a0;=&#x000a0;0.04) with the VR group reporting significantly less cases of anxiety and depression than the controls. Within the VR group at 12&#x000a0;months, significant correlations were found between positive patient perceptions of voice acceptability and the reduction in cases of anxiety (<italic>p</italic>&#x000a0;=&#x000a0;0.03, <italic>r</italic>
<sub>pb</sub>&#x000a0;=&#x000a0;&#x02212;0.38) and depression (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.001, <italic>r</italic>
<sub>pb</sub>&#x000a0;=&#x000a0;&#x02212;0.66).</p></sec><sec id="Sec8"><title>Discussion</title><p id="Par18">Results from the current study suggest associated positive effects on psychological well-being following voice rehabilitation. At baseline (post radiotherapy/pre-voice rehabilitation), both the control and VR groups were statistically similar in their reported cases of anxiety/depression, and results from this study are largely comparable to prior research which indicates that 15 and 23% of patients report anxiety and depression (respectively), immediately post radiotherapy [<xref ref-type="bibr" rid="CR13">13</xref>]. Following voice rehabilitation, our results demonstrate that there was a continued reduction in the proportion of patients with anxiety between baseline&#x02014;6&#x000a0;months&#x02014;and between 6 and 12&#x000a0;months within the VR group only. By 12&#x000a0;months, the proportion of anxiety (6%) and depression (6%) cases in the VR group were significantly lower than the control group where 25% continued to report ongoing anxiety or depression. The control group data in the current study is largely comparable to previous literature. Hammerlid et al. (1998) found 26 and 24% of their patients indicated anxiety and depression (respectively) at 12&#x000a0;months [<xref ref-type="bibr" rid="CR13">13</xref>] whilst, similarly, results from a cross sectional study reported that 32 and 25% of patients reported anxiety and depression (respectively) post laryngeal cancer treatment [<xref ref-type="bibr" rid="CR12">12</xref>]. Johansson et al. (2008), however, presented comparatively lower anxiety and depression figures at 12&#x000a0;months [<xref ref-type="bibr" rid="CR10">10</xref>]. These data from previous studies are generally congruent with this study&#x02019;s control group&#x02019;s proportions of anxiety and depression and further support the observations that our VR group presents with lower cases of anxiety and depression than typically reported for this population, 12&#x000a0;months post (C)RT.</p><p id="Par19">A number of possible theories could be proposed for why there were improved cases of anxiety and depression following voice rehabilitation. One possible reason could be the improved functional outcomes achieved by voice rehabilitation. Prior studies have reported positive voice function (acoustic and perceptual) outcomes following voice rehabilitation compared to no voice rehabilitation [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. Furthermore, Karlsson and colleagues (2015) demonstrated that voice rehabilitation significantly improved communication, social function, social contact and quality of life at 6&#x000a0;months post rehabilitation when compared to a control group [<xref ref-type="bibr" rid="CR19">19</xref>]. Indeed, in the current study, positive perceptions of voice acceptability were significantly correlated with fewer cases of anxiety and depression. This interrelationship and impact of function on quality of life and psychological well-being/distress is not a new phenomenon and has been reported both in the laryngeal cancer population [<xref ref-type="bibr" rid="CR20">20</xref>] in the larger HNC population [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>].</p><p id="Par20">However, it should be noted that the correlations between voice acceptability (the patient perceptions of voice function) and anxiety/depression were small to moderate in size. As such, additional factors contributing to the positive benefits observed for the VR group, such as broader impacts of behavioural intervention, should be considered. Within HNC trials, it has been observed that those trials which focus on improving function, as well as effective communication, problem-solving, and distress, result in reduced social impairment, psychological distress and improved HRQL [<xref ref-type="bibr" rid="CR30">30</xref>]. Given that our study&#x02019;s intervention arm focused on improving voice function, facilitating effective communication and transferring skills into the patient specific communication/social environment, it is possible that an improvement in these functional skills positively affected quality of life and patient well-being outcomes, secondary to the interrelation between these parameters.</p><p id="Par21">The current data raises some important clinical implications. Function rehabilitation post laryngeal cancer treatment has shown to improve communication and HRQL outcomes [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>] and, now, the current data supports potential positive benefits for patient well-being/distress. Furthermore, it is recognised more broadly in the literature that survivorship care should incorporate both function rehabilitation and psychosocial intervention [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR31">31</xref>&#x02013;<xref ref-type="bibr" rid="CR33">33</xref>]. Recent research within HNC literature, investigating behavioural and psychosocial intervention post treatment, suggests that structured, theoretically based interventions which address functional, HRQL and psychosocial impairments and incorporate problem-focused, self-management, collaborative goal-setting, action-planning, shared care and linkage to health-care supports are key elements for survivorship care [<xref ref-type="bibr" rid="CR31">31</xref>&#x02013;<xref ref-type="bibr" rid="CR33">33</xref>]. Although the current voice rehabilitation program used in this RCT was not developed with this specific focus, it has achieved some of these desired benefits. Future development of behavioural interventions for the laryngeal cancer population need to ensure that rehabilitation is sufficiently holistic to support the patient in their recovery, focusing on both function rehabilitation and psychosocial management.</p><p id="Par22">Limitations of this study include the heterogeneous laryngeal cancer cohort used within this study, including both glottic and supraglottic tumours and stage I&#x02013;stage IV cancers. However, the focus on voice rehabilitation within the laryngeal cancer population specifically versus the larger HNC population is also considered to be a strength of this study. Furthermore, our study&#x02019;s cohort is reflective of the usual laryngeal cancer demographics [<xref ref-type="bibr" rid="CR34">34</xref>]; therefore, results from this study may be generalisable to the larger laryngeal cancer patient population. It is acknowledged that no data on patient coping skills, adjustment, or other reasons for the observed levels of anxiety or depression were examined. As such, it is possible that other factors, unrelated to the voice rehabilitation, could account for the current findings. Investigation and incorporation of these factors are recommended for future trials.</p></sec><sec id="Sec9"><title>Conclusion</title><p id="Par23">Although voice rehabilitation has shown to improve functional outcomes and positively impact HRQL, the current data suggests positive associated effects of behavioural voice intervention on psychological distress/well-being. This study found lower rates of possible/probable anxiety and depression being reported at 6 and 12&#x000a0;months in the VR group compared to controls, and this improvement in anxiety/depression correlated moderately with patient perceptions of voice acceptability. Results highlight potential additional benefits of behavioural voice intervention beyond achieving direct change to voice function.</p></sec></body><back><ack><title>Acknowledgements</title><p>The authors acknowledge the Queensland Registration Board Legacy Fund and Speech Pathology Australia, Swedish Cancer Society, Assar Gabrielsson Foundation, The Larynx Foundation and Lions Cancer Foundation West, Sweden.</p></ack><notes notes-type="COI-statement"><title>Compliance with ethical standards</title><sec id="FPar1"><title>Conflict of interest</title><p id="Par24">The authors declare that they have no conflict of interest.</p></sec><sec id="FPar2"><title>Ethical approval</title><p id="Par25">All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karlsson</surname><given-names>T</given-names></name><name><surname>Bergstr&#x000f6;m</surname><given-names>L</given-names></name><name><surname>Ward</surname><given-names>E</given-names></name><name><surname>Finizia</surname><given-names>C</given-names></name></person-group><article-title>A prospective longitudinal study of voice characteristics and health-related quality of life outcomes following laryngeal cancer treatment with radiotherapy</article-title><source>Acta Oncol</source><year>2016</year><volume>55</volume><issue>6</issue><fpage>693</fpage><lpage>699</lpage><pub-id pub-id-type="doi">10.3109/0284186X.2016.1150604</pub-id><pub-id pub-id-type="pmid">27056401</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>DAL</given-names></name><name><surname>Robinson</surname><given-names>HF</given-names></name><name><surname>Marsh</surname><given-names>L</given-names></name><name><surname>Bradley</surname><given-names>PJ</given-names></name></person-group><article-title>Vocal quality 10 years after radiotherapy for early glottic cancer</article-title><source>Clin Radiol</source><year>1988</year><volume>39</volume><issue>3</issue><fpage>295</fpage><lpage>296</lpage><pub-id pub-id-type="doi">10.1016/S0009-9260(88)80541-5</pub-id><pub-id pub-id-type="pmid">3396281</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bibby</surname><given-names>JR</given-names></name><name><surname>Cotton</surname><given-names>SM</given-names></name><name><surname>Perry</surname><given-names>A</given-names></name><name><surname>Corry</surname><given-names>JF</given-names></name></person-group><article-title>Voice outcomes after radiotherapy treatment for early glottic cancer: assessment using multidimensional tools</article-title><source>Head &#x00026; neck</source><year>2008</year><volume>30</volume><issue>5</issue><fpage>600</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1002/hed.20750</pub-id><pub-id pub-id-type="pmid">18098302</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Molen</surname><given-names>L</given-names></name><name><surname>van Rossum</surname><given-names>MA</given-names></name><name><surname>Jacobi</surname><given-names>I</given-names></name><name><surname>van Son</surname><given-names>RJ</given-names></name><name><surname>Smeele</surname><given-names>LE</given-names></name><name><surname>Rasch</surname><given-names>CR</given-names></name><name><surname>Hilgers</surname><given-names>FJ</given-names></name></person-group><article-title>Pre- and posttreatment voice and speech outcomes in patients with advanced head and neck cancer treated with chemoradiotherapy: expert listeners&#x02019; and patients perception</article-title><source>J Voice</source><year>2012</year><volume>26</volume><issue>5</issue><fpage>e625</fpage><lpage>e633</lpage></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meleca</surname><given-names>RJ</given-names></name><name><surname>Dworkin</surname><given-names>JP</given-names></name><name><surname>Kewson</surname><given-names>DT</given-names></name><name><surname>Stachler</surname><given-names>RJ</given-names></name><name><surname>Hill</surname><given-names>SL</given-names></name></person-group><article-title>Functional outcomes following nonsurgical treatment for advanced-stage laryngeal carcinoma</article-title><source>Laryngoscope</source><year>2003</year><volume>113</volume><issue>4</issue><fpage>720</fpage><lpage>728</lpage><pub-id pub-id-type="doi">10.1097/00005537-200304000-00025</pub-id><pub-id pub-id-type="pmid">12671435</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peeters</surname><given-names>AJGE</given-names></name><name><surname>van Gogh</surname><given-names>CDL</given-names></name><name><surname>Goor</surname><given-names>K</given-names></name><name><surname>Verdonck-de Leeuw</surname><given-names>IM</given-names></name><name><surname>Langendijk</surname><given-names>JA</given-names></name><name><surname>Mahieu</surname><given-names>HF</given-names></name></person-group><article-title>Health status and voice outcome after treatment for T1a glottic carcinoma</article-title><source>European Archives of Oto-Rhino-Laryngology and Head &#x00026; Neck</source><year>2004</year><volume>261</volume><issue>10</issue><fpage>534</fpage><lpage>540</lpage><pub-id pub-id-type="doi">10.1007/s00405-003-0697-5</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szuecs</surname><given-names>M</given-names></name><name><surname>Kuhnt</surname><given-names>T</given-names></name><name><surname>Punke</surname><given-names>C</given-names></name><name><surname>Witt</surname><given-names>G</given-names></name><name><surname>Klautke</surname><given-names>G</given-names></name><name><surname>Kramp</surname><given-names>B</given-names></name><name><surname>Hildebrandt</surname><given-names>G</given-names></name></person-group><article-title>Subjective voice quality, communicative ability and swallowing after definitive radio (chemo)therapy, laryngectomy plus radio (chemo)therapy, or organ conservation surgery plus radio (chemo) therapy for laryngeal and hypopharyngeal cancer</article-title><source>J Radiat Res</source><year>2015</year><pub-id pub-id-type="pmid">25348250</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hocevar-Boltezar</surname><given-names>I</given-names></name><name><surname>Zargi</surname><given-names>M</given-names></name><name><surname>Strojan</surname><given-names>P</given-names></name></person-group><article-title>Risk factors for voice quality after radiotherapy for early glottic cancer</article-title><source>Radiother Oncol</source><year>2009</year><volume>93</volume><issue>3</issue><fpage>524</fpage><lpage>529</lpage><pub-id pub-id-type="doi">10.1016/j.radonc.2009.09.014</pub-id><pub-id pub-id-type="pmid">19846231</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergstr&#x000f6;m</surname><given-names>L</given-names></name><name><surname>Ward</surname><given-names>EC</given-names></name><name><surname>Finizia</surname><given-names>C</given-names></name></person-group><article-title>Voice rehabilitation for laryngeal cancer patients: functional outcomes and patient perceptions</article-title><source>The Laryngoscope:n/a-n/a</source><year>2016</year></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johansson</surname><given-names>M</given-names></name><name><surname>Ryden</surname><given-names>A</given-names></name><name><surname>Finizia</surname><given-names>C</given-names></name></person-group><article-title>Self evaluation of communication experiences after laryngeal cancer&#x02014;a longitudinal questionnaire study in patients with laryngeal cancer</article-title><source>BMC Cancer</source><year>2008</year><volume>8</volume><fpage>80</fpage><pub-id pub-id-type="doi">10.1186/1471-2407-8-80</pub-id><pub-id pub-id-type="pmid">18371189</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="other">Nordgren M, Abendstein H, Jannert M, Boysen M, Ahlner-Elmqvist M, Silander E, Bjordal K, Hammerlid E (2003) Health-related quality of life five years after diagnosis of laryngeal carcinoma. International Journal of Radiation Oncology Biology Physics 56 (5):1333-1343:10.1016/S0360-3016(03)00292-X</mixed-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siupsinskiene</surname><given-names>N</given-names></name><name><surname>Vaitkus</surname><given-names>S</given-names></name><name><surname>Grebliauskaite</surname><given-names>M</given-names></name><name><surname>Engelmanaite</surname><given-names>L</given-names></name><name><surname>Sumskiene</surname><given-names>J</given-names></name></person-group><article-title>Quality of life and voice in patients treated for early laryngeal cancer</article-title><source>Medicina Kaunas, Lithuania</source><year>2008</year><volume>44</volume><issue>4</issue><fpage>288</fpage><lpage>295</lpage><pub-id pub-id-type="pmid">18469505</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammerlid</surname><given-names>E</given-names></name><name><surname>Mercke</surname><given-names>C</given-names></name><name><surname>Sullivan</surname><given-names>M</given-names></name><name><surname>Westin</surname><given-names>T</given-names></name></person-group><article-title>A prospective quality of life study of patients with laryngeal carcinoma by tumor stage and different radiation therapy schedules</article-title><source>Laryngoscope</source><year>1998</year><volume>108</volume><issue>5</issue><fpage>747</fpage><lpage>759</lpage><pub-id pub-id-type="doi">10.1097/00005537-199805000-00023</pub-id><pub-id pub-id-type="pmid">9591558</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singer</surname><given-names>S</given-names></name><name><surname>Danker</surname><given-names>H</given-names></name><name><surname>Dietz</surname><given-names>A</given-names></name><name><surname>Hornemann</surname><given-names>B</given-names></name><name><surname>Koscielny</surname><given-names>S</given-names></name><name><surname>Oeken</surname><given-names>J</given-names></name><name><surname>Matthaus</surname><given-names>C</given-names></name><name><surname>Vogel</surname><given-names>H</given-names></name><name><surname>Krauss</surname><given-names>O</given-names></name></person-group><article-title>Screening for mental disorders in laryngeal cancer patients: a comparison of 6 methods</article-title><source>Psychooncology</source><year>2008</year><volume>17</volume><issue>3</issue><fpage>280</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1002/pon.1229</pub-id><pub-id pub-id-type="pmid">17614095</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johansson</surname><given-names>M</given-names></name><name><surname>Ryden</surname><given-names>A</given-names></name><name><surname>Finizia</surname><given-names>C</given-names></name></person-group><article-title>Mental adjustment to cancer and its relation to anxiety, depression, HRQL and survival in patients with laryngeal cancer. A longitudinal study</article-title><source>BMC Cancer</source><year>2011</year><volume>11</volume><issue>1</issue><fpage>283</fpage><pub-id pub-id-type="doi">10.1186/1471-2407-11-283</pub-id><pub-id pub-id-type="pmid">21718478</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Gogh</surname><given-names>CD</given-names></name><name><surname>Verdonck-de Leeuw</surname><given-names>IM</given-names></name><name><surname>Boon-Kamma</surname><given-names>BA</given-names></name><name><surname>Rinkel</surname><given-names>RN</given-names></name><name><surname>de Bruin</surname><given-names>MD</given-names></name><name><surname>Langendijk</surname><given-names>JA</given-names></name><name><surname>Kuik</surname><given-names>DJ</given-names></name><name><surname>Mahieu</surname><given-names>HF</given-names></name></person-group><article-title>The efficacy of voice therapy in patients after treatment for early glottic carcinoma</article-title><source>Cancer</source><year>2006</year><volume>106</volume><issue>1</issue><fpage>95</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1002/cncr.21578</pub-id><pub-id pub-id-type="pmid">16323175</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Gogh</surname><given-names>CDL</given-names></name><name><surname>Verdonck-de Leeuw</surname><given-names>IM</given-names></name><name><surname>Langendijk</surname><given-names>JA</given-names></name><name><surname>Kuik</surname><given-names>DJ</given-names></name><name><surname>Mahieu</surname><given-names>HF</given-names></name></person-group><article-title>Long-term efficacy of voice therapy in patients with voice problems after treatment of early glottic cancer</article-title><source>J Voice</source><year>2012</year><volume>26</volume><issue>3</issue><fpage>398</fpage><lpage>401</lpage><pub-id pub-id-type="doi">10.1016/j.jvoice.2011.06.002</pub-id><pub-id pub-id-type="pmid">21840168</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuomi</surname><given-names>L</given-names></name><name><surname>Andr&#x000e9;ll</surname><given-names>P</given-names></name><name><surname>Finizia</surname><given-names>C</given-names></name></person-group><article-title>Effects of voice rehabilitation after radiation therapy for laryngeal cancer: a randomized controlled study</article-title><source>International Journal of Radiation Oncology Biology Physics</source><year>2014</year><volume>89</volume><issue>5</issue><fpage>964</fpage><lpage>972</lpage><pub-id pub-id-type="doi">10.1016/j.ijrobp.2014.04.030</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karlsson</surname><given-names>T</given-names></name><name><surname>Johansson</surname><given-names>M</given-names></name><name><surname>Andr&#x000e9;ll</surname><given-names>P</given-names></name><name><surname>Finizia</surname><given-names>C</given-names></name></person-group><article-title>Effects of voice rehabilitation on health-related quality of life, communication and voice in laryngeal cancer patients treated with radiotherapy: a randomised controlled trial</article-title><source>Acta Oncol</source><year>2015</year><volume>54</volume><issue>7</issue><fpage>110171024</fpage><pub-id pub-id-type="doi">10.3109/0284186X.2014.995773</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rinkel</surname><given-names>RNPM</given-names></name><name><surname>Verdonck-de Leeuw</surname><given-names>IM</given-names></name><name><surname>van den Brakel</surname><given-names>N</given-names></name><name><surname>de Bree</surname><given-names>R</given-names></name><name><surname>Eerenstein</surname><given-names>SEJ</given-names></name><name><surname>Aaronson</surname><given-names>N</given-names></name><name><surname>Leemans</surname><given-names>CR</given-names></name></person-group><article-title>Patient-reported symptom questionnaires in laryngeal cancer: voice, speech and swallowing</article-title><source>Oral Oncol</source><year>2014</year><volume>50</volume><issue>8</issue><fpage>759</fpage><lpage>764</lpage><pub-id pub-id-type="doi">10.1016/j.oraloncology.2014.05.009</pub-id><pub-id pub-id-type="pmid">24954064</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pocock</surname><given-names>SJ</given-names></name><name><surname>Simon</surname><given-names>R</given-names></name></person-group><article-title>Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial</article-title><source>Biometrics</source><year>1975</year><volume>31</volume><issue>1</issue><fpage>103</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.2307/2529712</pub-id><pub-id pub-id-type="pmid">1100130</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zigmond</surname><given-names>A</given-names></name><name><surname>Snaith</surname><given-names>R</given-names></name></person-group><article-title>The Hospital Anxiety and Depression Scale</article-title><source>Acta Psychiatr Scand</source><year>1983</year><volume>67</volume><fpage>361</fpage><lpage>370</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0447.1983.tb09716.x</pub-id><pub-id pub-id-type="pmid">6880820</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stern</surname><given-names>AF</given-names></name></person-group><article-title>The Hospital Anxiety and Depression Scale</article-title><source>Occup Med</source><year>2014</year><volume>64</volume><issue>5</issue><fpage>393</fpage><lpage>394</lpage><pub-id pub-id-type="doi">10.1093/occmed/kqu024</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finizia</surname><given-names>C</given-names></name><name><surname>Hammerlid</surname><given-names>E</given-names></name><name><surname>Westin</surname><given-names>T</given-names></name><name><surname>Lindstr&#x000f6;m</surname><given-names>J</given-names></name></person-group><article-title>Quality of life and voice in patients with laryngeal carcinoma, a posttreatment comparison of laryngectomy (salvage surgery) versus radiotherapy</article-title><source>Laryngoscope</source><year>1998</year><volume>108</volume><issue>10</issue><fpage>1566</fpage><lpage>1573</lpage><pub-id pub-id-type="doi">10.1097/00005537-199810000-00027</pub-id><pub-id pub-id-type="pmid">9778303</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finizia</surname><given-names>C</given-names></name><name><surname>Lindstr&#x000f6;m</surname><given-names>J</given-names></name><name><surname>Dotevall</surname><given-names>H</given-names></name></person-group><article-title>Intelligibility and perceptual ratings after treatment for laryngeal cancer: laryngectomy versus radiotherapy</article-title><source>Laryngoscope</source><year>1998</year><volume>108</volume><issue>1</issue><fpage>138</fpage><lpage>143</lpage><pub-id pub-id-type="doi">10.1097/00005537-199801000-00027</pub-id><pub-id pub-id-type="pmid">9432084</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="other">Lowry R (2016) VassarStats: Website for Stastical Computation. Retrieved from <ext-link ext-link-type="uri" xlink:href="http://vassarstats.net/pbcorr.html">http://vassarstats.Net/pbcorr.Html</ext-link>. Accessed 8 august, 2016.</mixed-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hinkle</surname><given-names>D</given-names></name><name><surname>Wiersma</surname><given-names>W</given-names></name><name><surname>Jurs</surname><given-names>S</given-names></name></person-group><source>Applied statistics for the behavioral sciences</source><year>2003</year><publisher-loc>Boston, Massachusetts</publisher-loc><publisher-name>Houghton Mifflin</publisher-name></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ringash</surname><given-names>J</given-names></name></person-group><article-title>Survivorship and quality of life in head and neck cancer</article-title><source>J Clin Oncol</source><year>2015</year><volume>33</volume><issue>29</issue><fpage>3322</fpage><lpage>3327</lpage><pub-id pub-id-type="doi">10.1200/JCO.2015.61.4115</pub-id><pub-id pub-id-type="pmid">26351336</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aarstad</surname><given-names>HJ</given-names></name><name><surname>Osthus</surname><given-names>AA</given-names></name><name><surname>Olofsson</surname><given-names>J</given-names></name><name><surname>Aarstad</surname><given-names>AKH</given-names></name></person-group><article-title>Level of distress predicts subsequent survival in successfully treated head and neck cancer patients a prospective cohort study</article-title><source>Acta Otolaryngol</source><year>2014</year><volume>134</volume><issue>2</issue><fpage>211</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.3109/00016489.2013.841989</pub-id><pub-id pub-id-type="pmid">24256042</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howren</surname><given-names>MB</given-names></name><name><surname>Christensen</surname><given-names>AJ</given-names></name><name><surname>Karnell</surname><given-names>LH</given-names></name><name><surname>Funk</surname><given-names>GF</given-names></name></person-group><article-title>Psychological factors associated with head and neck cancer treatment and survivorship, evidence and opportunities for behavioral medicine</article-title><source>J Consult Clin Psychol</source><year>2013</year><volume>81</volume><issue>2</issue><fpage>299</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1037/a0029940</pub-id><pub-id pub-id-type="pmid">22963591</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McEwen</surname><given-names>SE</given-names></name><name><surname>Davis</surname><given-names>AM</given-names></name><name><surname>Jones</surname><given-names>JM</given-names></name><name><surname>Martino</surname><given-names>R</given-names></name><name><surname>Poon</surname><given-names>I</given-names></name><name><surname>Rodriguez</surname><given-names>AM</given-names></name><name><surname>Ringash</surname><given-names>J</given-names></name></person-group><article-title>Development and preliminary evaluation of a rehabilitation consult for survivors of head and neck cancer: an intervention mapping protocol</article-title><source>Implement Sci</source><year>2015</year><volume>10</volume><issue>1</issue><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1186/s13012-014-0195-8</pub-id><pub-id pub-id-type="pmid">25567289</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>J</given-names></name><name><surname>Yates</surname><given-names>P</given-names></name><name><surname>Kenny</surname><given-names>L</given-names></name><name><surname>Gordon</surname><given-names>LG</given-names></name><name><surname>Burmeister</surname><given-names>B</given-names></name><name><surname>Thomson</surname><given-names>D</given-names></name><name><surname>Hughes</surname><given-names>B</given-names></name><name><surname>McCarthy</surname><given-names>AL</given-names></name><name><surname>Perry</surname><given-names>C</given-names></name><name><surname>Chan</surname><given-names>RJ</given-names></name><name><surname>Fraser</surname><given-names>A</given-names></name><name><surname>Skerman</surname><given-names>H</given-names></name><name><surname>Batstone</surname><given-names>M</given-names></name><name><surname>Carswell</surname><given-names>K</given-names></name></person-group><article-title>The ENHANCES study&#x02014;enhancing head and neck cancer patients experiences of survivorship: study protocol for a randomized controlled trial</article-title><source>Trials</source><year>2014</year><volume>15</volume><issue>1</issue><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1186/1745-6215-15-191</pub-id><pub-id pub-id-type="pmid">24382030</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Meulen</surname><given-names>IC</given-names></name><name><surname>May</surname><given-names>AM</given-names></name><name><surname>de Leeuw</surname><given-names>JRJ</given-names></name><name><surname>Koole</surname><given-names>R</given-names></name><name><surname>Oosterom</surname><given-names>M</given-names></name><name><surname>Hordijk</surname><given-names>GJ</given-names></name><name><surname>Ros</surname><given-names>WJG</given-names></name></person-group><article-title>Long-term effect of a nurse-led psychosocial intervention on health-related quality of life in patients with head and neck cancer a randomised controlled trial</article-title><source>Br J Cancer</source><year>2014</year><volume>110</volume><issue>3</issue><fpage>593</fpage><lpage>601</lpage><pub-id pub-id-type="doi">10.1038/bjc.2013.733</pub-id><pub-id pub-id-type="pmid">24280999</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="other">Statistikdatabas f&#x000f6;r. cancer (2014) Socialstyrelsen, Stockholm. <ext-link ext-link-type="uri" xlink:href="http://www.socialstyrelsen.se/statistik/statistikdatabas/cancer">http://www.socialstyrelsen.se/statistik/statistikdatabas/cancer</ext-link>. Accessed 20 September, 2016</mixed-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piccirillo</surname><given-names>JF</given-names></name><name><surname>Tierney</surname><given-names>RM</given-names></name><name><surname>Costas</surname><given-names>I</given-names></name><name><surname>Grove</surname><given-names>L</given-names></name><name><surname>Spitznagel</surname><given-names>EL</given-names><suffix>Jr</suffix></name></person-group><article-title>Prognostic importance of comorbidity in a hospital-based cancer registry</article-title><source>JAMA</source><year>2004</year><volume>291</volume><issue>20</issue><fpage>2441</fpage><lpage>2447</lpage><pub-id pub-id-type="doi">10.1001/jama.291.20.2441</pub-id><pub-id pub-id-type="pmid">15161894</pub-id></element-citation></ref></ref-list></back></article>